Among all patients tested for MMR deficiency at our institution, only 4.5% were found to be deficient, and only 5.3% of patients with uterine carcinosarcoma were found to be MMR deficient. This evidence concerns the gene MRC1 and hyperinsulinemic hypoglycemia, familial, 4.